Hematopoietic stem cell mobilization with G-CSF

Methods in Molecular Biology

Volumn 904, Issue , 2012, Pages 37-47

  Hosing, Chitra ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Allogeneic stem cell transplantation; Autologous stem cell transplantation; G CSF; Hematopoietic stem cell mobilization

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; LACTATE DEHYDROGENASE; PLERIXAFOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STROMAL CELL DERIVED FACTOR 1ALPHA;

ALLOTRANSPLANTATION; ANAPHYLAXIS; ANKYLOSING SPONDYLITIS; ARTHRALGIA; ARTICLE; BONE PAIN; BRAIN HEMORRHAGE; CANCER CHEMOTHERAPY; CAPILLARY LEAK SYNDROME; CHILL; DEGRANULATION; DIARRHEA; DOSE RESPONSE; DRUG HALF LIFE; EPISCLERITIS; FATIGUE; FEVER; FLU LIKE SYNDROME; GOUT; HEADACHE; HEART INFARCTION; HUMAN; INSOMNIA; IRITIS; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MULTIPLE MYELOMA; MYALGIA; NAUSEA; OPTIMAL DRUG DOSE; PARESTHESIA; PRIORITY JOURNAL; RASH; RHEUMATOID ARTHRITIS; RIGOR; SICKLE CELL BETA THALASSEMIA; SICKLE CELL CRISIS; SPLEEN RUPTURE; STEM CELL MOBILIZATION; UNSTABLE ANGINA PECTORIS; VOMITING;

EID: 84934439761     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-943-3_3     Document Type: Article

References (62)

1. Goodman JW, Hodgson GS (1962) Evidence for stem cells in the peripheral blood of mice. Blood 19:702-714
2. McCredie KB, Hersh EM, Freireich EJ (1971) Cells capable of colony formation in the peripheral blood of man. Science 171:293-294
3. Weiner RS, Richman CM, Yankee RA (1977) Semicontinuous flow centrifugation for the pheresis of immunocompetent cells and stem cells. Blood 49:391-397
4. Hillyer CD, Tiegerman KO, Berkman EM (1991) Increase in circulating colony-forming units-granulocyte-macrophage during large-volume leukapheresis: evaluation of a new cell separator. Transfusion 31:327-332
5. Korbling M, Dorken B, Ho AD, Pezzutto A, Hunstein W, Fliedner TM (1986) Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood 67:529-532
6. Goldman JM (1979) Autografting cryopre-served buffy coat cells for chronic granulocytic leukaemia in transformation. Exp Hematol 7(Suppl 5):389-397
7. Kessinger A, Smith DM, Strandjord SE, Landmark JD, Dooley DC, Law P, Coccia PF, Warkentin PI, Weisenburger DD, Armitage JO (1989) Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 4:643-646
8. Dreger P, Suttorp M, Haferlach T, Loffler H, Schmitz N, Schroyens W (1993) Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 81:1404-1407
9. Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA, Witherspoon RP, Bensinger W, Flowers ME, Martin P, Storb R, Appelbaum FR, Boeckh M (2001) Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97:3380-3389
10. Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, Kashyap A, Flowers ME, Lilleby K, Chauncey TR, Storb R, Appelbaum FR (2001) Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hema-tologic cancers. N Engl J Med 344:175-181
11. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HM, Link H, Zander A, Barge A (1996) Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347:353-357
12. Product information. Leukine (sargrastim). W.B.H. and Pharmaceuticals, A, Seattle Product information. Neupagen (filgrastim). Amgen Inc., Thousand Oaks, CA
13. Anderlini P, Rizzo JD, Nugent ML, Schmitz N, Champlin RE, Horowitz MM (2001) Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant 27:689-692
14. Curran MP, Goa KL (2002) Peg filgrastim. Drugs 62:1207-1213, discussion 1214-1205
15. Isidori A, Tani M, Bonifazi F, Zinzani P, Curti A, Motta MR, Rizzi S, Giudice V, Farese O, Rovito M, Alinari L, Conte R, Baccarani M, Lemoli RM (2005) Phase II study of a single peg filgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. Haematologica 90:225-231
16. Grigg AP, Roberts AW, Raunow H, Houghton S, Layton JE, Boyd AW, McGrath KM, Maher D (1995) Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 86:4437-4445
17. Molineux G, Kinstler O, Briddell B, Hartley C, McElroy P, Kerzic P, Sutherland W, Stoney G, Kern B, Fletcher FA, Cohen A, Korach E, Ulich T, McNiece I, Lockbaum P, Miller-Messana MA, Gardner S, Hunt T, Schwab G (1999) A new form of filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans. Exp Hematol 27:1724-1734
18. Johnston E, Crawford J, Blackwell S, Bjurstrom T, Lockbaum P, Roskos L, Yang BB, Gardner S, Miller-Messana MA, Shoemaker D, Garst J, Schwab G (2000) Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy. J Clin Oncol 18:2522-2528
19. Hosing C, Qazilbash MH, Kebriaei P, Giralt S, Davis MS, Popat U, Anderlini P, Shpall EJ, McMannis J, Korbling M, Champlin RE (2006) Fixed-dose single agent peg filgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma. Br J Haematol 133:533-537
20. Nademanee A, Sniecinski I, Schmidt GM, Dagis AC, O'Donnell MR, Snyder DS, Parker PM, Stein AS, Smith EP, Molina A et al (1994) High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. J Clin Oncol 12:2176-2186
21. Gazitt Y, Freytes CO, Callander N, Tsai TW, Alsina M, Anderson J, Holle L, Cruz J, Devore P, McGrath M, West G, Alvarez R, Montgomery W (1999) Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization. J Hematother 8:173-183
22. Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift R, Lilleby K, Williams B, Storb R, Thomas ED, Buckner CD (1993) The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 81:1883-1888
23. Anderlini P, Przepiorka D, Champlin R, Korbling M (1996) Peripheral blood stem cell apheresis in normal donors: the neglected side. Blood 88:3663-3664
24. Waller CF, Bertz H, Wenger MK, Fetscher S, Hardung M, Engelhardt M, Behringer D, Lange W, Mertelsmann R, Finke J (1996) Mobilization of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen. Bone Marrow Transplant 18:279-283
25. Bishop MR, Tarantolo SR, Jackson JD, Anderson JR, Schmit-Pokorny K, Zacharias D, Pavletic ZS, Pirruccello SJ, Vose JM, Bierman PJ, Warkentin PI, Armitage JO, Kessinger A (1997) Allogeneic-blood stem-cell collection following mobilization with low-dose granulo-cyte colony-stimulating factor. J Clin Oncol 15:1601-1607
26. Sato N, Sawada K, Takahashi TA, Mogi Y, Asano S, Koike T, Sekiguchi S (1994) A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony-stimulating factor in healthy volunteers. Exp Hematol 22:973-978
27. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD (1995) Transplantation of alloge-neic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655-1658
28. Kroger N, Zeller W, Fehse N, Hassan HT, Kruger W, Gutensohn K, Lolliger C, Zander AR (1998) Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients. Br J Haematol 102:1101-1106
29. Hoglund M, Smedmyr B, Simonsson B, Totterman T, Bengtsson M (1996) Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF. Bone Marrow Transplant 18:19-27
30. Stroncek DF, Clay ME, Petzoldt ML, Smith J, Jaszcz W, Oldham FB, McCullough J (1996) Treatment of normal individuals with granulo-cyte-colony- stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 36:601-610
31. Link H, Arseniev L, Bahre O, Berenson RJ, Battmer K, Kadar JG, Jacobs R, Casper J, Kuhl J, Schubert J, Diedrich H, Poliwoda H (1995) Combined transplantation of allogeneic bone marrow and CD34+ blood cells. Blood 86:2500-2508
32. Wuchter P, Ran D, Bruckner T, Schmitt T, Witzens-Harig M, Neben K, Goldschmidt H, Ho AD (2010) Poor mobilization of hematopoietic stem cells-de finitions, incidence, risk factors, and impact on outcome of autologous transplantation. Biol Blood Marrow Transplant 16:490-499
33. Winkler IG, Levesque JP (2006) Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone. Exp Hematol 34:996-1009
34. Semerad CL, Christopher MJ, Liu F, Short B, Simmons PJ, Winkler I, Levesque JP, Chappel J, Ross FP, Link DC (2005) G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106:3020-3027
35. Winkler IG, Hendy J, Coughlin P, Horvath A, Levesque JP (2005) Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilization. J Exp Med 201:1077-1088
36. Anderlini P, Przepiorka D, Champlin R, Korbling M (1996) Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 88:2819-2825
37. Anderlini P, Donato M, Chan KW, Huh YO, Gee AP, Lauppe MJ, Champlin RE, Korbling M (1999) Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion 39:555-560
38. Abboud M, Laver J, Blau CA (1998) Granulocytosis causing sickle-cell crisis. Lancet 351:959
39. Adler BK, Salzman DE, Carabasi MH, Vaughan WP, Reddy VV, Prchal JT (2001) Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood 97:3313-3314
40. Grigg AP (2001) Granulocyte colony-stimulating factor-induced sickle cell crisis and mul-tiorgan dysfunction in a patient with compound heterozygous sickle cell/beta + thalassemia. Blood 97:3998-3999
41. Kang EM, Areman EM, David-Ocampo V, Fitzhugh C, Link ME, Read EJ, Leitman SF, Rodgers GP, Tisdale JF (2002) Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait. Blood 99:850-855
42. Anderlini P, Korbling M, Dale D, Gratwohl A, Schmitz N, Stroncek D, Howe C, Leitman S, Horowitz M, Gluckman E, Rowley S, Przepiorka D, Champlin R (1997) Allogeneic blood stem cell transplantation: considerations for donors. Blood 90:903-908
43. Stroncek DF, Clay ME, Herr G, Smith J, Ilstrup S, McCullough J (1997) Blood counts in healthy donors 1 year after the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection. Transfusion 37:304-308
44. Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL (2009) Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood 113:3604-3611
45. Anderlini P, Przepiorka D, Seong D, Miller P, Sundberg J, Lichtiger B, Norfleet F, Chan KW, Champlin R, Korbling M (1996) Clinical tox-icity and laboratory effects of granulocyte-col-ony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion 36:590-595
46. Holig K, Kramer M, Kroschinsky F, Bornhauser M, Mengling T, Schmidt AH, Rutt C, Ehninger G (2009) Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood 114:3757-3763
47. Miflin G, Charley C, Stainer C, Anderson S, Hunter A, Russell N (1996) Stem cell mobilization in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy. Br J Haematol 95:345-348
48. Cavallaro AM, Lilleby K, Majolino I, Storb R, Appelbaum FR, Rowley SD, Bensinger WI (2000) Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 25:85-89
49. Kroschinsky F, Holig K, Poppe-Thiede K, Zimmer K, Ordemann R, Blechschmidt M, Oelschlaegel U, Bornhauser M, Rall G, Rutt C, Ehninger G (2005) Single-dose peg filgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors. Haematologica 90:1665-1671
50. Stroncek DF, Clay ME, Jaszcz W, Lennon S, Smith J, McCullough J (1999) Collection of two peripheral blood stem cell concentrates from healthy donors. Transfus Med 9:37-50
51. Nuamah NM, Goker H, Kilic YA, Dagmoura H, Cakmak A (2006) Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literature. Haematologica 91:ECR08
52. Becker PS, Wagle M, Matous S, Swanson RS, Pihan G, Lowry PA, Stewart FM, Heard SO (1997) Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an alloge-neic donor of peripheral blood stem cells. Biol Blood Marrow Transplant 3:45-49
53. de Azevedo AM, Goldberg Tabak D (2001) Life-threatening capillary leak syndrome after G-CSF mobilization and collection of peripheral blood progenitor cells for allogeneic transplantation. Bone Marrow Transplant 28:311-312
54. Arimura K, Inoue H, Kukita T, Matsushita K, Akimot M, Kawamata N, Yamaguchi A, Kawada H, Ozak A, Arima N, Te C (2005) Acute lung injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone. Haematologica 90:ECR10
55. Vij R, Adkins DR, Brown RA, Khoury H, DiPersio JF, Goodnough T (1999) Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte-colony-stimu-lating factor. Transfusion 39:542-543
56. Bensinger WI, Buckner CD, Rowley S, Storb R, Appelbaum FR (1996) Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells. Bone Marrow Transplant 17(Suppl 2):S19-S21
57. Parkkali T, Volin L, Siren MK, Ruutu T (1996) Acute iritis induced by granulocyte colony-stimulating factor used for mobilization in a volunteer unrelated peripheral blood progenitor cell donor. Bone Marrow Transplant 17:433-434
58. Huhn RD, Yurkow EJ, Tushinski R, Clarke L, Sturgill MG, Hoffman R, Sheay W, Cody R, Philipp C, Resta D, George M (1996) Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granu-locyte colony-stimulating factor (rhG-CSF) in normal volunteers. Exp Hematol 24:839-847
59. Storek J, Glaspy JA, Grody WW, Susi E, Slater ED (1993) Adult-onset cyclic neutropenia responsive to cyclosporine therapy in a patient with ankylosing spondylitis. Am J Hematol 43:139-143
60. Spitzer T, McAfee S, Poliquin C, Colby C (1998) Acute gouty arthritis following recombinant human granulocyte colony-stimulating factor therapy in an allogeneic blood stem cell donor. Bone Marrow Transplant 21:966-967
61. Pei RZ, Ma JX, Zhang PS, Liu XH, Cao JJ, Du XH (2008) Intracranial hemorrhage caused by cerebrovascular malformation after donation of rhG-CSF-primed allogeneic PBSC. Bone Marrow Transplant 42:61-62
62. Adkins DR (1998) Anaphylactoid reaction in a normal donor given granulocyte colony-stimulating factor. J Clin Oncol 16:812-813